Mayo Foundation for Medical Education and Research
发明人:
Svetomir N. Markovic,Wendy K. Nevala
申请号：
US15430411
公开号：
US20170232102A1
申请日:
2017.02.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed herein are improved compositions and methods involved in treating hematologic cancers, i.e., cancers that begin in blood-forming tissue, such as the bone marrow, or in the cells of the immune system. The compositions comprise complexes containing albumin-containing nanoparticles (e.g., ABRAXANE® nanoparticles) and antibodies. The compositions are used to effect hematologic cancer cell death.
